Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilaralisib in advanced or recurrent endometrial carcinoma
NCT01013324Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pilaralisib in endometrial cancer (EC), sponsored by Sanofi. Started Jan 2010; status: completed.
02
Drugs
pilaralisib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01013324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013324.